Protective effect of linalool against lipopolysaccharide/d-galactosamine-induced liver injury in mice

International Immunopharmacology

Volumn 23, Issue 2, 2014, Pages 523-529

  Li, Jingyuan ^a   Zhang, Xiaoyu ^a   Huang, Haiying ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

d Galactosamine; Linalool; Lipopolysaccharide; NF B; Nrf2

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CASPASE 8; CYCLOOXYGENASE 2; GALACTOSAMINE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LINALOOL; LIPOPOLYSACCHARIDE; MALONALDEHYDE; PROTEIN BCL 2; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; INTERLEUKIN-6, MOUSE; LIPOPOLYSACCHARIDE, E COLI O55-B5; NFE2L2 PROTEIN, MOUSE; NOS2 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE; TERPENE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME INHIBITION; EXPERIMENTAL LIVER INJURY; LETHALITY; LIPID PEROXIDATION; LIVER HOMOGENATE; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SURVIVAL RATE; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BLOOD; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; ENZYMOLOGY; IMMUNOLOGY; LIVER FUNCTION TEST; METABOLISM; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYCLOOXYGENASE 2; DRUG-INDUCED LIVER INJURY; GALACTOSAMINE; INTERLEUKIN-6; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LIVER FUNCTION TESTS; MALE; MICE, INBRED BALB C; MONOTERPENES; NF-E2-RELATED FACTOR 2; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84912523474     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.10.001     Document Type: Article

References (39)

1. K.K. Sogaard, E. Horvath-Puho, H. Gronbaek, P. Jepsen, H. Vilstrup, and H.T. Sorensen Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study Am J Gastroenterol 104 2009 96 101
2. R.J. Andrade, M.I. Lucena, M.C. Fernandez, G. Pelaez, K. Pachkoria, and E. Garcia-Ruiz Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period Gastroenterology 129 2005 512 [2005;129:1808]
3. A.I. Cederbaum, Y.K. Lu, and D.F. Wu Role of oxidative stress in alcohol-induced liver injury Arch Toxicol 83 2009 519 548
4. T.J. Davern, N. Chalasani, R.J. Fontana, P.H. Hayashi, P. Protiva, and D.E. Kleiner Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury Gastroenterology 141 2011 1665-U215
5. W.C. Lee, J.K. Kim, J.W. Kang, W.Y. Oh, J.Y. Jung, and Y.S. Kim Palmatine attenuates d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice Food Chem Toxicol 48 2010 222 228
6. X. Lin, S.J. Zhang, R.B. Huang, S.M. Tan, S. Liang, and X.Y. Wu Protective effect of tormentic acid from Potentilla chinensis against lipopolysaccharide/d-galactosamine induced fulminant hepatic failure in mice Int Immunopharmacol 19 2014 365 372
7. X.Y. Wang, L.N. Zhang, Z.T. Wei, X. Zhang, Q. Gao, and Y.Y. Ma The inhibitory action of PDCD4 in lipopolysaccharide/d-galactosamine-induced acute liver injury Lab Invest 93 2013 291 [2013;93:1164]
8. Q. Ai, Y. Jing, R. Jiang, L. Lin, J. Dai, and Q. Che Rotenone, a mitochondrial respiratory complex I inhibitor, ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatitis in mice Int Immunopharmacol 21 2014 200 207
9. A.T. Peana, S. Marzocco, A. Popolo, and A. Pinto (-)-Linalool inhibits in vitro NO formation: probable involvement in the antinociceptive activity of this monoterpene compound Life Sci 78 2006 719 723
10. R. Ravizza, M.B. Gariboldi, R. Molteni, and E. Monti Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells Oncol Rep 20 2008 625 630
11. A.T. Peana, P.S. D'Aquila, F. Panin, G. Serra, P. Pippia, and M.D. Moretti Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils Phytomedicine 9 2002 721 726
12. M.X. Huo, X.R. Cui, J.D. Xue, G.F. Chi, R.J. Gao, and X.M. Deng Anti-inflammatory effects of linalool in RAW 264.7 macrophages and lipopolysaccharide-induced lung injury model J Surg Res 180 2013 E47 E54
13. H. Nyblom, U. Berggren, J. Balldin, and R. Olsson High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking Alcohol Alcohol 39 2004 336 339
14. E. Bjornsson, and R. Olsson Outcome and prognostic markers in severe drug-induced liver disease Hepatology 42 2005 481 489
15. J. Smith, S. Rao, B. Jovanovic, and S.L. Flamm AST: ALT ratio > 1 predicts increased fibrosis stage but is not an accurate predictor of advanced fibrosis/cirrhosis in patients with chronic hepatitis C virus (HCV) infection Gastroenterology 118 2000 A974 A975
16. J.E. Krawisz, P. Sharon, and W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models Gastroenterology 87 1984 1344 1350
17. W.C. Lee, H.A. Jung, J.S. Choi, Y.S. Kim, and S.M. Lee Protective effects of luteolin against apoptotic liver damage induced by d-galactosamine/lipopolysaccharide in mice J Nat Prod 74 2011 1916 1921
18. D.S. Yu, F.M. An, B.D. Gong, X.G. Xiang, L.Y. Lin, and H. Wang The regulatory role of microRNA-1187 in TNF-alpha-mediated hepatocyte apoptosis in acute liver failure Int J Mol Med 29 2012 663 668
19. R.M. Thushara, M. Hemshekhar, M.S. Santhosh, S. Devaraja, K. Kemparaju, and K.S. Girish Differential action of phytochemicals on platelet apoptosis: a biological overview Curr Med Chem 20 2013 1018 1027
20. J.L. Coloff, A.N. Macintyre, A.G. Nichols, T.Y. Liu, C.A. Gallo, and D.R. Plas Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition Cancer Res 71 2011 5204 5213
21. S.B. Yee, P.E. Ganey, and R.A. Roth The role of Kupffer cells and TNF-alpha in monocrotaline and bacterial lipopolysaccharide-induced liver injury Toxicol Sci 71 2003 124 132
22. Y. Iimuro, R.M. Gallucci, M.I. Luster, H. Kono, and R.G. Thurman Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat Hepatology 26 1997 1530 1537
23. Z. Ben-Ari, V. Zilbermints, O. Pappo, O. Avlas, E. Sharon, and F. Greif Erythropoietin increases survival and attenuates fulminant hepatic failure injury induced by d-galactosamine/lipopolysaccharide in mice Transplantation 92 2011 18 24
24. X. Xia, C. Su, J. Fu, P. Zhang, X. Jiang, and D. Xu Role of alpha-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis Int Immunopharmacol 22 2014 293 302
25. H. Liu, X. Wu, Z. Dong, Z. Luo, Z. Zhao, and Y. Xu Fatty acid synthase causes drug resistance by inhibiting TNF-alpha and ceramide production J Lipid Res 54 2013 776 785
26. K.C. McGrath, X.H. Li, P.T. Whitworth, R. Kasz, J.T. Tan, and S.V. McLennan High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation J Lipid Res 55 2014 421 430
27. H. Yu, M. Valerio, and J. Bielawski Fenretinide inhibited de novo ceramide synthesis and proinflammatory cytokines induced by Aggregatibacter actinomycetemcomitans J Lipid Res 54 2013 189 201
28. S. Uda, S. Spolitu, F. Angius, M. Collu, S. Accossu, and S. Banni Role of HDL in cholesteryl ester metabolism of lipopolysaccharide-activated P388D1 macrophages J Lipid Res 54 2013 3158 3169
29. Z. Zhao, X. Tang, X. Zhao, M. Zhang, W. Zhang, and S. Hou Tylvalosin exhibits anti-inflammatory property and attenuates acute lung injury in different models possibly through suppression of NF-kappaB activation Biochem Pharmacol 90 2014 73 87
30. Y.F. Chuang, H.Y. Yang, T.L. Ko, Y.F. Hsu, J.R. Sheu, and G. Ou Valproic acid suppresses lipopolysaccharide-induced cyclooxygenase-2 expression via MKP-1 in murine brain microvascular endothelial cells Biochem Pharmacol 88 2014 372 383
31. O. Altan, A. Pabuccuoglu, A. Altan, S. Konyalioglu, and H. Bayraktar Effect of heat stress on oxidative stress, lipid peroxidation and some stress parameters in broilers Br Poult Sci 44 2003 545 550
32. D. Del Rio, A.J. Stewart, and N. Pellegrini A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress Nutr Metab Cardiovasc 15 2005 316 328
33. B. Sid, C. Glorieux, M. Valenzuela, G. Rommelaere, M. Najimi, and N. Dejeans AICAR induces Nrf2 activation by an AMPK-independent mechanism in hepatocarcinoma cells Biochem Pharmacol 91 2014 168 180
34. C.C. Chen, C.B. Chu, K.J. Liu, C.Y. Huang, J.Y. Chang, and W.Y. Pan Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification Biochem Pharmacol 86 2013 872 887
35. C. Zhang, Z.Y. Su, T.O. Khor, L. Shu, and A.N. Kong Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation Biochem Pharmacol 85 2013 1398 1404
36. M.P. Mollica, G. Trinchese, G. Cavaliere, C. De Filippo, E. Cocca, and M. Gaita c9, t11-conjugated linoleic acid ameliorates steatosis by modulating mitochondrial uncoupling and Nrf2 pathway J Lipid Res 55 2014 837 849
37. C.F. Chang, X.M. Liu, K.J. Peyton, and W. Durante Heme oxygenase-1 counteracts contrast media-induced endothelial cell dysfunction Biochem Pharmacol 87 2014 303 311
38. J.L. Ehren, and P. Maher Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetin Biochem Pharmacol 85 2013 1816 1826
39. Z. Liu, J. Wang, E. Huang, S. Gao, H. Li, and J. Lu Tanshinone IIA suppresses cholesterol accumulation in human macrophages: role of heme oxygenase-1 J Lipid Res 55 2014 201 213